This is a molecular diagnostic test that checks the base sequence of cancer-related genes to identify the molecular characteristics of a patient’s cancer cells.

The presence of mutation of target gene can be checked using DNA extracted from the patient’s cancer cells, which can serve as a basis for using targeted therapeutics such as specific TKIs (Tyrosine kinase inhibitors).

Genes for which sequencing can be performed: KIT, BRAF, KRAS, HER2, EGFR, PIK3CA